Annual report [Section 13 and 15(d), not S-K Item 405]

INCOME (LOSS) PER SHARE AND SHAREHOLDERS' EQUITY

v3.25.0.1
INCOME (LOSS) PER SHARE AND SHAREHOLDERS' EQUITY
12 Months Ended
Dec. 31, 2024
Income (Loss) Per Share And Shareholders' Equity [Abstract]  
INCOME (LOSS) PER SHARE AND SHAREHOLDERS' EQUITY

8. INCOME (LOSS) PER SHARE AND SHAREHOLDERS’ EQUITY

Income (Loss) Per Share

The following table presents the computation of basic and diluted income (loss) per share for 2024 and 2023 (in thousands, except per share data):

 

 

Years Ended December 31,

 

 

 

2024

 

 

2023

 

Numerator:

 

 

 

 

 

 

Net income (loss)

 

$

14,741

 

 

$

(24,402

)

 

 

 

 

 

 

 

Denominator:

 

 

 

 

 

 

Weighted average basic shares

 

 

16,370

 

 

 

16,193

 

Effect of dilutive share-based awards

 

 

385

 

 

 

 

Weighted average diluted shares

 

 

16,755

 

 

 

16,193

 

 

 

 

 

 

 

 

Basic income (loss) per share

 

$

0.90

 

 

$

(1.51

)

Diluted income (loss) per share

 

$

0.88

 

 

$

(1.51

)

 

Shareholders’ Equity

On December 1, 2023, our Board approved a share repurchase program (“Share Repurchase Program”) authorizing the repurchase of up to $5.0 million of our outstanding common stock, effective from December 15, 2023 through December 15, 2024. On October 31, 2024, our Board extended the Share Repurchase Program to December 31, 2025. The timing and amount of any share repurchases under the Share Repurchase Program is at the discretion of management and may be made from time to time through transactions in the open market, in privately negotiated transactions or by other means in accordance with applicable laws. The Share Repurchase Program does not obligate us to repurchase any shares of common stock and may be modified, increased, suspended or terminated at the discretion of our Board. During 2024 and 2023, we repurchased 230,938 and 29,578 shares of our common stock for $1.2 million and $0.1 million, respectively, and at December 31, 2024, we had remaining authorization to purchase up to $3.7 million of our outstanding common stock under the Share Repurchase Program.